Article Information
History
- February 19, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Stefania Dispinseri, PhD1,
- Massimiliano Secchi, PhD2,
- Maria Franca Pirillo, PhD3,
- Monica Tolazzi, MSc1,
- Martina Borghi, BSc4,
- Cristina Brigatti, MSc2,
- Maria Laura De Angelis, PhD5,
- Marco Baratella, PhD1,
- Elena Bazzigaluppi, MSc2,
- Giulietta Venturi, PhD4,
- Francesca Sironi, MSc1,
- Andrea Canitano, PhD3,
- Ilaria Marzinotto, PhD2,
- Cristina Tresoldi, MSc6,
- Fabio Ciceri, MD7,8,
- Lorenzo Piemonti, MD2,8,
- Donatella Negri, PhD4,
- Andrea Cara, PhD3,
- Vito Lampasona, MSc2 and
- Gabriella Scarlatti, MD1,*
- 1Viral Evolution and Transmission Unit, IRCCS Ospedale San Raffaele, Milan, Italy
- 2Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy
- 3National Center for Global Health, Istituto Superiore di Sanità, Rome, Italy
- 4Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy
- 5Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy
- 6Molecular Hematology Unit, IRCCS Ospedale San Raffaele, Milan, Italy
- 7Hematology and Bone Marrow Transplantation Unit, IRCCS Ospedale San Raffaele, Milan, Italy
- 8School of Medicine and Surgery, Università Vita-Salute San Raffaele, Milan, Italy
- ↵*Corresponding Author:
Gabriella Scarlatti, Viral Evolution and Transmission Unit, Department of Immunology, Transplant and Infectious Diseases, IRCCS Ospedale San Raffaele, Via Olgettina 58, 20132 Milan, Italy. Email: scarlatti.gabriella{at}hsr.it, Phone:+39 0226434906
SD, MS, MFP and AC, VL, GS have equally contributed.
Posted February 19, 2021.
COVID-BioB Cohort Study: the neutralizing antibody response to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for virus control and survival
